Angels for Change Launches Project GOLD to Address Drug Shortages

Healthcare professional reviewing oncology medication supplies

Article Sponsored by:

Community Resource Consultants Inc. (CRCI)

Community Resource Consultants Inc. (CRCI) is a Michigan-based organization specializing in trauma rehabilitation medical case management. With over 34 years of experience, CRCI is dedicated to empowering survivors of catastrophic auto accidents to regain control of their lives and achieve both physical and emotional well-being. Their team of Licensed Master Social Workers (LMSWs) and Registered Nurses (RNs) are experts in navigating the complexities of today’s healthcare system, ensuring that survivors receive the necessary services for their recovery and rehabilitation. CRCI’s core values include advocacy, people, knowledge, and dependability, reflecting their commitment to being leading advocates and facilitators of long-term collaborative care.

News Summary

Angels for Change has launched Project GOLD, aimed at tackling cancer drug shortages by establishing a buffer supply of essential medications. The initiative, supported by key pharmaceutical players, seeks to ensure continuous patient care during shortages and improve drug availability in oncology. Project GOLD’s long-term vision is to create a comprehensive emergency supply of oncology medications at risk of shortages.

Angels for Change Unveils Project GOLD to Tackle Cancer Drug Shortages

In an inspiring move to combat the pressing issue of cancer drug shortages, Angels for Change has officially announced the pilot launch of Project GOLD, a bold initiative aimed at ensuring a stable supply of essential cancer medications. This innovative program is all set to make waves in how we address drug shortages in the oncology sector, and it’s being backed by some significant players in the pharmaceutical world.

What is Project GOLD?

So what exactly is Project GOLD? It’s designed to create an onshore buffer supply of six vital medications used in cancer treatment. The goal here is straightforward: to provide a reliable lifeline for patients during times when these critical drugs may be in short supply. By collaborating with leading pharmaceutical distributors and manufacturers, this initiative aims to keep patient care seamless, even in challenging circumstances.

The Dream Team Behind Project GOLD

Launching this groundbreaking pilot are some key contributors in the pharmaceutical landscape: Cencora, McKesson, and Fresenius Kabi. Each of these organizations has stepped up to the plate, investing in resiliency programs and joining forces to tackle the ongoing drug shortages that are hitting hospitals hard.

How Will It Work?

The first phase of Project GOLD is all about proactive engagement. This includes building up buffer inventories, fostering collaboration among stakeholders, and advocating for patients who might be affected by shortages. Over the next six months, the program will focus on ensuring that disruptions in patient care become a thing of the past.

The Stakes Are High

99% of hospital pharmacists report grappling with at least one essential drug shortage daily, putting countless lives at risk. For oncology patients, the threat is even more pronounced, with more than half of surveyed pharmacists having to delay or cancel treatments due to a scarcity of medicines. As it stands, oncology products represent the largest class of medications in shortage for 2023, and that’s where Project GOLD steps in.

Aiming for the Long Haul

While the immediate focus is on these six essential medicines, the long-term vision for Project GOLD is ambitious. The ultimate aim is to maintain a comprehensive emergency supply of all oncology medications that are at risk of shortages. This could be a game changer for U.S. patients suffering from cancer, ensuring they have consistent access to their vital treatments without the fear of rationed care.

Collaboration is Key

The success of Project GOLD hinges on strong partnerships across the pharmaceutical supply chain. By connecting proven resiliency programs with the A4C Drug Shortage Hotline, the initiative seeks to streamline the process of patient care during shortages and make vital medications available when they are most needed.

Milestones Already Achieved

Since its launch, Project GOLD has already reached three significant milestones, which showcases the proactive steps being implemented to tackle this issue head-on. This is the first project of its kind in the United States specifically aimed at addressing drug shortages within the oncology sector, and it’s about time we see some action.

A Future of Hope

As Angels for Change embarks on this crucial journey, it’s clear that they are committed to making a difference in the lives of cancer patients. This initiative represents a unique blend of care, collaboration, and dedication, and the hope is that it will set a new standard for how the healthcare system can respond to the persistent problem of drug shortages. With the support of industry leaders and an unwavering focus on patient-centered care, Project GOLD stands as a beacon of hope in the fight against cancer.